Search Results
148 items found for "Shan-He Yu"
- Ep 48 with Dr Nyla Naim Dr Michael Lemieux Dr Jason Nasse from Addgene
He obtained his Ph.D. in Neuroscience from Ohio State University focusing on synaptic plasticity and
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Yuling Feng The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial cell identity and Yuling Feng Abstract Only available for AGPCR 24 Workshop Attendees Authors & Affiliations "Shen,Tingzhen About Yuling Feng "I am currently a postdoctoral research fellow working with aGPCR pharmacology and Yuling Feng on the web LinkedIn The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial He was trained in molecular biology at the Universities of Fribourg and Lausanne, Switzerland where he
- Booklet for participants | Dr. GPCR Ecosystem
2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF You can also download the booklet by scanning
- Trainee Symposium I
He recently received his BSc in pharmacology from the University of Sherbrooke in 2023.
- Ep 125 with Dr. Gregory Tall
He has continued funding at Michigan through the MIRA R35 program. Dr.
- GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway
Authors Yaoxin Gao, Weirong Zhan, Dandan Guo, Haizhen Lin, Muhammad Asad Farooq, Chenxu Jin, Li Zhang , Ying Zhou, Jie Yao, Yixin Duan, Cong He, Shuai Jiang, Wenzheng Jiang Tags DCs , GPR97 , Keratinocytes
- Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
The incidence of severe infections was higher with BsAb (40%) than CAR-T (26%) or ADC (8%), including rates (IRR:2.27, 1.31-3.98, P = 0.004) and time to severe infection (HR 2.04, 1.05-3.96, P = 0.036) than 0.21-0.93, P = 0.032) and incidence rate (IRR:0.32, 95% 0.17-0.59, P < 0.001) of severe infections than , Hani Hassoun, Kylee Maclachlan, Neha Korde, Urvi A Shah, Carlyn Rose Tan, Malin Hultcrantz, Sergio A Giralt, Saad Z Usmani, Zainab Shahid, Sham Mailankody, Alexander M Lesokhin Source Contribute to the
- Terms and Conditions | Dr. GPCR Ecosystem
If Customer(s) choose(s) to register for the Services, he/she/they agree(s) to provide and maintain true Accordingly, the Customer acknowledges that he is solely responsible for adequate security, protection DISCLAIMER OF WARRANTIES: CUSTOMER AGREES THAT HE/SHE/IT IS MAKING USE OF THE SERVICES AT HIS/SHE/ITS
- Ep 150 with Dr GPCR Team
Further down the track, he aims to apply this knowledge to develop novel chemical treatments for neuronal
- Retreat | Dr. GPCR Ecosystem
We're thrilled that you've taken the time to scan our QR code and join us at the GPCR Retreat.
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
Fractional exhaled nitric oxide , G-protein-coupled receptor , GPCR , Group 2 innate lymphoid cell , HES
- Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
, Vincent DiGiacomo , Mariola Ferreras-Gutierrez , Shiva Dastjerdi , Alain Ibáñez de Opakua , Jong-Chan
- In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity
Differential scanning fluorimetry showed AJ-3 to bind RGS2 but not Gαq.
- Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes
Biswas, Michael J Miller, Julia E Myers, Stephen M Matthews, Amanda B Wass, Christine M O'Connor, Gary C Chan
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
About Yimin Zou "I received Ph.D from University of California at Davis and San Diego in 1995 and then postdoctoral training from University of California, San Francisco in 2000. I became full professor in 2011 and Vice Chair of the Neurobiology Department at UC San Diego in 2012 I served as the Chair of the Neurobiology Department at UC San Diego from 2014 to 2017. As a clinician, he specializes in surgical treatment of brain tumors.
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Sabbagh was recruited by Vertex Pharmaceuticals (Canada) where he worked on biomarker discovery for inflammatory
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Many biological forces are smaller than 200 pN, the force that is needed to separate the TA from the As an undergraduate, he studied opioid receptor trafficking and G protein conformational dynamics in
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
By directly scanning and comparing energetic sequences of reaction steps, the most likely pathway and
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Tour, Food and drinks Read More Oct 24 - 9:00 AM Session II AGPCR signaling pathways and trafficking Yuling Kordon · Tingzhen Shen · Bill Huang · Júlia Rosell · Sheila Ribalta-Mena · Mariam Melkumyan Read More modulation of dopaminergic neurotransmission Signe Mathiasen Signaling Properties of ADGRL3 Tingzhen Shen for Human Adhesion GPCRs Tyler Bernadyn Elucidating The Role Of GPR97/ADGRG3 In Neutrophil Biology Yuling
- Itaconate in host inflammation and defense
Authors Dan Ye , Pu Wang , Lei-Lei Chen , Kun-Liang Guan , Yue Xiong Tags IRG1/ACOD1 , cancer , inflammatory
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
KS-133 reduced the percentage of cells in the S phase more than treatment with U0126 or ZSTK474 alone Atsuko Hayata-Takano , Takanobu Nakazawa , Souichi Yanamoto , Kotaro Tanimoto , Hitoshi Hashimoto , Yukio
- The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
Authors Yukio Tonozuka , Hiroshi Tanaka , Kazumi Nomura , Kazuya Sakaguchi , Junpei Soeda , Yoshihide
- Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway
and cAMP response element binding protein (Ser133) in VIPR2-overexpressing MCF-7 cells was greater than Kotaro Sakamoto , Atsuko Hayata-Takano , Takanobu Nakazawa , Kotaro Tanimoto , Hitoshi Hashimoto , Yukio
- SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma
Authors Yue Xu , Zihan Quan , Yuting Zhan , Haihua Wang , Jiadi Luo , Weiyuan Wang , Songqing Fan Tags
- Interplay between G protein-coupled receptors and nanotechnology
Authors Yuhong Jiang , Yuke Li , Xiujuan Fu , Yue Wu , Rujing Wang , Mengnan Zhao , Canquan Mao , Sanjun
- GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis
Authors Kairong Liang , Zhaoxiong Guo , Shizhen Zhang , Danmin Chen , Renheng Zou , Yuhao Weng , Chengxiang Peng , Zhichao Xu , Jingbai Zhang , Xiaorui Liu , Xiao Pang , Yunxiang Ji , Degui Liao , Miaoling Lai
- The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
Authors Victoria H Wu , Bryan S Yung , Farhoud Faraji , Robert Saddawi-Konefka , Zhiyong Wang , Alexander
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
Authors Yuxin Wang , Bao Jin , Xiangan Wu , Jiali Xing , Baoluhe Zhang , Xiaokun Chen , Xiao Liu , Xueshuai